Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study

International Journal of Cancer

Volumn 120, Issue 10, 2007, Pages 2221-2225

  Genkinger, Jeanine M ^a   DeVivo, Immaculata ^a,b   Stampfer, Meir J ^a,b   Giovannucci, Edward ^a,b   Michaud, Dominique S ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bladder cancer; Cohort; Epidemiology; NSAID use

Indexed keywords

ACETYLSALICYLIC ACID; ANACIN; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DRUG USE; FLUID INTAKE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING;

ACETAMINOPHEN; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; FOLLOW-UP STUDIES; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 34147124796     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22546     Document Type: Article

References (53)

1. American Cancer Society. Cancer facts and figures 2005. Atlanta: American Cancer Society, 2005.
2. Madeb R, Messing EM. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004;22:86-92.
3. Reis LAGEM, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK. SEER Cancer Statistics Review, 1975-2002, based on November 2004 SEER data submission, posted to the SEER web site 2005. National Cancer Institute, 2005. Available at http://seer.cancer.gov/csr/1975_2002/.
4. Bedwani R, el-Khwsky F, Renganathan E, Braga C, Abu Seif HH, Abul Azm T, Zaki A, Franceschi S, Boffetta P, La Vecchia C. Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer 1997;73:64-7.
5. Slattery ML, Schumacher MC, West DW, Robison LM. Smoking and bladder cancer. The modifying effect of cigarettes on other factors. Cancer 1988;61:402-8.
6. Bonassi S, Merlo F, Pearce N, Puntoni R. Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer 1989; 44:648-51.
7. Vineis P, Ciccone G, Ghisetti V, Terracini B. Cigarette smoking and bladder cancer in females. Cancer Lett 1985;26:61-6.
8. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004;21:392-401.
9. Amonkar P, Murali G, Krishnamurfhy S. Schistosoma induced squamous cell carcinoma of the bladder. Indian J Pathol Microbiol 2001;44:363-4.
10. Cooppan RM, Bhoola KD, Mayet FG. Schistosomiasis and bladder carcinoma in Natal. S Afr Med J 1984;66:841-3.
11. Chevrier C, Junod B, Cordier S. Does ozonation of drinking water reduce the risk of bladder cancer? Epidemiology 2004;15:605-14.
12. Villanueva CM, Fernandez F, Malats N, Grimalt JO, Kogevinas M. Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health 2003;57:166-73.
13. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 2003;14:303-10.
14. Guo HR, Chiang HS, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidemiology 1997; 8:545-50.
15. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005;294:914-23.
16. Garcia Rodriguez LA, Gonzalez-Perez A. Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer 2004;91:525-9.
17. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's health initiative. Cancer Res 2003;63:6096-101.
18. Sandler RS, Galanko JC, Murray SC, Helm JF, Woosley JT. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. Gastroenterology 1998;114:441-7.
19. Thun MJ. NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Am 1996;25:333-18.
20. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2003; 95:1784-91.
21. Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 2000;82:1364-9.
22. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF, Jr. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 1984;119:510-15.
23. La Vecchia C, Negri E, D'Avanzo B, Savoldelli R, Franceschi S. Genital and urinary tract diseases and bladder cancer. Cancer Res 1991;51:629-31.
24. Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med. Rehabil 2002;83:346-51.
25. Chow WH, Lindblad P, Gridley G, Nyren O, McLaughlin JK, Linet MS, Pennello GA, Adami HO, Fraumeni JF, Jr. Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 1997;89: 1453-7.
26. Koraitim MM, Metwalli NE, Atta MA, el-Sadr AA. Changing age incidence and pathological types of schistosoma-associated bladder carcinoma. J Urol 1995;154:1714-16.
27. Shariat SF, Kim JH, Ayala GE, Kho K, Wheeler TM, Lerner SP. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol 2003;169:938-42.
28. Shariat SF, Matsumoto K, Kim J, Ayala GE, Zhou JH, Jian W, Benedict WF, Lerner SP. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. J Urol 2003;170:985-9.
29. Yoshimura R, Sano H, Mitsuhashi M, Kohno M, Chargui J, Wada S. Expression of cyclooxygenase-2 in patients with bladder carcinoma. J Urol 2001;165:1468-72.
30. Dannenberg AJ, Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cells 2003;4: 431-6.
31. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Cyclooxygenase in biology and disease. FASEB J 1998;12:1063-73.
32. Howe GR, Burch JD, Miller AB, Cook GM, Esteve J, Morrison B, Gordon P, Chambers LW, Fodor G, Winsor GM. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 1980;64:701-13.
33. Steineck G, Wiholm BE, Gerhardsson de Verdier M. Acetaminophen, some other drugs, some diseases and the risk of transitional cell carcinoma. A population-based case-control study. Acta Oncol 1995;34: 741-8.
34. Fortuny J, Kogevinas M, Garcia-Closas M, Real FX, Tardon A, Garcia-Closas R, Serra C, Carrato A, Lloreta J, Rothman N, Villanueva C, Dosemeci M et al. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Cancer Epidemiol Biomarkers Prev 2006;15:1696-702.
35. Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 2004;24:3177-84.
36. Fokkens W. Phenacetin abuse related to bladder cancer. Environ Res 1979;20:192-8.
37. McCredie M, Stewart JH, Ford JM, MacLennan RA. Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol 1983;55:220-4.
38. Johansson SL. Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetaminophen). Int J Cancer 1981;27:521-9.
39. Piper JM, Tonascia J, Matanoski GM. Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. N Engl J Med 1985;313:292-5.
40. McCredie M, Stewart JH, Day NE. Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer 1993;53:245-9.
41. McCredie M, Stewart JH, Ford JM. Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis. J Urol 1983;130:28-30.
42. McLaughlin JK, Blot WJ, Mehl ES, Fraumeni JF, Jr. Relation of analgesic use to renal cancer: population-based findings. Natl Cancer Inst Monogr 1985;69:217-22.
43. Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med 1983;308:357-62.
44. Flaks B, Flaks A, Shaw AP. Induction by paracetamol of bladder and liver tumours in the rat. Effects on hepatocyte fine structure. Acta Pathol Microbiol Immunol Scand [A] 1985;93:367-77.
45. Flaks A, Flaks B. Induction of liver cell tumours in IF mice by paracetamol. Carcinogenesis 1983;4:363-8.
46. Derby LE, Jick H. Acetaminophen and renal and bladder cancer. Epidemiology 1996;7:358-62.
47. Rosenberg L, Rao RS, Palmer JR, Strom BL, Zauber A, Warshauer ME, Stolley PD, Shapiro S. Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States). Cancer Causes Control 1998;9:83-8.
48. Dorkin TJ, Robson CN, Neal DE. The molecular pathology of urological malignancies. J Pathol 1997;183:380-7.
49. Michaud DS, Clinton SK, Rimm EB, Willett WC, Giovannucci E. Risk of bladder cancer by geographic region in a US cohort of male health professionals. Epidemiology 2001;12:719-26.
50. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC, Giovannucci EL. Fluid intake and the risk of bladder cancer in men. N Engl J Med 1999;340:1390-7.
51. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
52. Patrono C, Coller B, Dalen JE, FitzGerald GA, Fuster V, Gent M, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 2001;119:S39-S63.
53. Holick CN, Michaud DS, Leitzmann MF, Willett WC, Giovannucci E. Aspirin use and lung cancer in men. Br J Cancer 2003;89:1705-8.